Crkl Polyclonal Antibody, FITC Conjugated
Product Specifications
Background
Crkl is a 34kDa adaptor protein which has been shown to activate the RAS and JUN kinase signalling pathways and transforms fibroblasts in a RAS dependant manner. Crkl is a substitute of BCR ABL tyrosine kinase. In addition, Crkl has oncogenic potential.
Synonyms
Crk-like protein; CRKL
Gene ID
1399
Swiss Prot
P46109
Cellular Locus
Cytoplasm, Nucleus
Host
Rabbit
Cross Reactivity
Mouse, Rat
Immunogen
201-303/303
Target
Crkl
Clonality
Polyclonal
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human Crkl
Applications
IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
1µg/µl
Dilution
IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
1399
Predicted Cross Reactivity
Human, Cow, Pig, Horse, Rabbit
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
034834-ML650 100 µL
DTL, ID (DTL, CDT2, CDW1, DCAF2, L2DTL, RAMP, Denticleless protein homolog, DDB1- and CUL4-associated factor 2, Lethal (2) denticleless protein homolog, Retinoic acid-regulated nuclear matrix-associated protein) (MaxLight 650) discontinued
Ask
View Details 219165-01 20 µL
PRAME (Preferentially Expressed Antigen In Melanoma, MAPE, OIP4, CT130, OIP-4) discontinued
Ask
View Details 
219165-02 100 µL
PRAME (Preferentially Expressed Antigen In Melanoma, MAPE, OIP4, CT130, OIP-4) discontinued
Ask
View Details